Cell Preparation for 3D Tissue Culture via Adherence Sorting

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current 2D cell culture methods are inadequate for predicting in vivo drug efficacy and toxicity due to their inability to accurately represent the 3D environment, leading to unreliable results and the presence of non-viable cells that can interfere with tissue functionality.

Innovation Solution

A method involving cell plating to assess adherence and viability, followed by discarding non-adherent cells, which allows for the selection of viable cells for 3D tissue culture, using techniques like FACS for further sorting, and employing methods such as hanging drop cultures or scaffold-based approaches to form high-quality 3D tissues.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of information

If cell viability assays are used to assess overall cell viability, then information on overall cell viability is obtained, but no information on individual cell viability is provided and non-viable cells cannot be separated

Engineering Contradiction:
Improveinformation on individual cell viabilityVSAvoidcell separation capability
Core Design Contradiction:
Loss of informationVSDevice complexity

Solution Approach 1:

The cell population is segmented into viable and non-viable subpopulations based on individual cell characteristics (adherence capability, size, granularity) rather than treating the population as a homogeneous group. This segmentation enables identification and separation of individual non-viable cells that would otherwise be indistinguishable in bulk assays.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent replaces traditional mechanical separation methods with flow cytometry-based sorting, which uses optical detection and electrical charging to identify and separate cells based on their physical and physiological properties. This substitution enables precise individual cell sorting without mechanical manipulation.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Ease of manufacture

If 2D monolayer cell cultures are used, then cell culture is simplified, but the cultures are inadequate representations of in vivo tissue environment and provide unreliable predictions of drug efficacy and toxicity

Engineering Contradiction:
Improvecell culture simplicityVSAvoidprediction accuracy of drug efficacy and toxicity
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent transitions from two-dimensional monolayer cultures to three-dimensional tissue cultures, adding the vertical dimension of cell organization. This dimensional change enables cells to form spheroids or organoids with internal structures, cell-cell interactions, and gradients that mimic in vivo tissue architecture and physiology, thereby improving predictive reliability while maintaining experimental tractability.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Productivity

If non-viable cells are not removed before 3D tissue culture, then the culture process is simpler, but non-viable cells interfere with tissue functionality and prevent proper organotypic architecture formation

Engineering Contradiction:
Improveculture process efficiencyVSAvoidtissue functionality and stability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent performs preliminary sorting and removal of non-viable cells before initiating the 3D tissue culture process. This preliminary action ensures that only viable, functional cells are used to construct the tissue, preventing interference with tissue formation and ensuring proper organotypic architecture. The upfront investment in cell sorting prevents downstream failures and improves overall culture success rates.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly improves the quality and functionality of 3D tissues by removing non-viable cells, resulting in superior tissue morphology, viability, and stability, enabling more accurate drug screenings and regenerative medicine applications.

Implementation Method 1

b) optionally, checking for their capability to adhere to said surface, c) discarding the cells which have not adhered to said surface

Methodology Applied
Scientific EffectCell adhesion: Adhesive

Data Source

PatentEP3132023B1Method of preparing cells for 3D tissue culture
Publication Date: 2021.06.02 INSPHERO AG
  • EP3132023B1 patent drawingFigure 1A~1B
  • EP3132023B1 patent drawingFigure 2
  • EP3132023B1 patent drawingFigure 3a~3b

AI summary

The present invention relates to a method of preparing cells for 3D tissue culture, which method comprises the steps of plating the cells on a suitable surface, optionally, checking for their capability to adhere to said surface, discarding the cells which have not adhered to said surface, detaching the adhered cells and transferring them into a 3D tissue culture process.